Status:
UNKNOWN
Treatment Effect of Cross-frequency Transcranial Alternating Current Stimulation on the MUD
Lead Sponsor:
Shanghai Mental Health Center
Conditions:
Amphetamine-Related Disorders
Eligibility:
All Genders
18-59 years
Phase:
NA
Brief Summary
The purpose of this research is to evaluate the efficacy of multiple sessions of theta-gamma cross-frequency transcranial alternating current stimulation in patients with methamphetamine (MA) use diso...
Detailed Description
Previous evidence suggests that different aspects of cognitive function are associated with activities of distinct EEG frequency bands. Gamma oscillatory has been found in clinical studies to reflect ...
Eligibility Criteria
Inclusion
- In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders
- Normal vision and hearing
- Dextromanual
- Use MA not less than 1 year, and the last of MA use no less than 3 months
Exclusion
- Have a disease that affects cognitive function such as a history of head injury, cerebrovascular disease, epilepsy, etc
- Have cognitive-promoting drugs in the last 6 months
- Other substance abuse or dependence in recent five years (except nicotine)
- Meet the DSM-5 criteria for other mental disorders
- Physical disease
Key Trial Info
Start Date :
October 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06145698
Start Date
October 15 2023
End Date
February 15 2024
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan Compulsory Rehabilitation Center
Wuhan, China, 430000